![[dr. bob]](/dr-bob-sm.gif)
Dr. Bob is Robert Hsiung, MD,
bob@dr-bob.orgShown: posts 1 to 3 of 3. This is the beginning of the thread.
Posted by hok on February 25, 2003, at 18:42:33
If Nardil is the most superior of the MAOIs, why isn't its manufacturer looking to put it into a transdermal patch form like Somerset pharmaceuticals is doing for Selegiline?
Wouldn't it be the most ideal candidate for transdermal delivery?
Posted by stjames on February 25, 2003, at 18:57:03
In reply to Why not patch form of Nardil insteadof Selegiline?, posted by hok on February 25, 2003, at 18:42:33
Not everything can be delivered via the transdermal route.
Posted by Thomas123 on February 25, 2003, at 19:53:27
In reply to Re: Why not patch form of Nardil insteadof Selegiline?, posted by stjames on February 25, 2003, at 18:57:03
Most likely because there is a bigger market for selegiline. Selegiline is used in Parkinson's disease where Nardil isn't.
This is the end of the thread.
Psycho-Babble Medication | Extras | FAQ
Dr. Bob is Robert Hsiung, MD,
bob@dr-bob.org
Script revised: February 4, 2008
URL: http://www.dr-bob.org/cgi-bin/pb/mget.pl
Copyright 2006-17 Robert Hsiung.
Owned and operated by Dr. Bob LLC and not the University of Chicago.